- Home
- REPL vs MVST Comparison
REPL vs MVST Comparison
Compare REPL & MVST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPL
- MVST
- Stock Information
- Founded
- REPL 2015
- MVST 2006
- Country
- REPL United States
- MVST United States
- Employees
- REPL N/A
- MVST N/A
- Industry
- REPL Biotechnology: Pharmaceutical Preparations
- MVST Industrial Machinery/Components
- Sector
- REPL Health Care
- MVST Miscellaneous
- Exchange
- REPL Nasdaq
- MVST Nasdaq
- Market Cap
- REPL 578.4M
- MVST 676.9M
- IPO Year
- REPL 2018
- MVST N/A
- Fundamental
- Price
- REPL $8.00
- MVST $1.83
- Analyst Decision
- REPL Strong Buy
- MVST Strong Buy
- Analyst Count
- REPL 6
- MVST 1
- Target Price
- REPL $20.00
- MVST $3.00
- AVG Volume (30 Days)
- REPL 967.9K
- MVST 8.7M
- Earning Date
- REPL 05-15-2025
- MVST 05-08-2025
- Dividend Yield
- REPL N/A
- MVST N/A
- EPS Growth
- REPL N/A
- MVST N/A
- EPS
- REPL N/A
- MVST N/A
- Revenue
- REPL N/A
- MVST $379,801,000.00
- Revenue This Year
- REPL $31.16
- MVST $24.47
- Revenue Next Year
- REPL N/A
- MVST $25.25
- P/E Ratio
- REPL N/A
- MVST N/A
- Revenue Growth
- REPL N/A
- MVST 23.87
- 52 Week Low
- REPL $4.92
- MVST $0.15
- 52 Week High
- REPL $17.00
- MVST $2.87
- Technical
- Relative Strength Index (RSI)
- REPL 36.82
- MVST 59.50
- Support Level
- REPL $6.44
- MVST $1.61
- Resistance Level
- REPL $7.97
- MVST $1.80
- Average True Range (ATR)
- REPL 0.73
- MVST 0.23
- MACD
- REPL 0.08
- MVST 0.03
- Stochastic Oscillator
- REPL 41.47
- MVST 91.36
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3.
About MVST Microvast Holdings Inc.
Microvast Holdings Inc is a technology innovator that designs, develops, and manufactures lithium-ion battery solutions. It is renowned for its cutting-edge cell technology and its vertical integration capabilities which extend from core battery chemistry to battery packs.